The FDA has approved the first drug for the treatment of Huntington's disease.
Regardless of where we practice, increasingly we are confronted with patients who have been exposed to unusual diseases through travel. In a previous series of articles, we reviewed the diseases associated with travel, largely based on the geography. This article reviews infectious disease associated with travel by symptoms.
This second publication from the COURAGE investigators reports on multiple assessments of quality of life, particularly angina presence and severity, between the two groups over the study observation.
Diabetic patients are at higher risk for in-stent restenosis and stent thrombosis than their non-diabetic counterparts.
The management of anticoagulation in patients requiring long-term warfarin therapy is often problematic when they need cardiac catheterization.
In patients with elevated triglycerides, other atherogenic particles may be as important as LDL-cholesterol (C). These particles and LDL-C are measured as non-HDL-C, and are considered a secondary target of therapy.
The relationship between physical activity and atrial fibrillation has been controversial. Lone atrial fibrillation is relatively common in young, competitive athletes, and it is uncertain whether routine physical activity is protective or harmful in elderly populations where atrial fibrillation is more common.
The sudden cardiac death in heart failure trial (SCD-HeFT) was a study involving patients with ischemic and non-ischemic cardiomyopathy and a left ventricular ejection fraction < 35% and class II or III heart failure that tested the value of ICD therapy for the primary prevention of sudden cardiac death.
